… Cardiovascular complications due to COVID-19, such as right ventricular dysfunction, are …
care units of patients with COVID-19 pneumonitis whose lungs were mechanically ventilated. …

… in hospitalised patients with confirmed COVID-19 pneumonitis. Patients were assigned
randomly … nafamostat as an add on therapy for patients hospitalised with COVID-19 pneumonitis. …

… Upon ruling out superimpose and nosocomial infections, we recommend resuming high-dose
corticosteroids in people with COVID-19-induced respiratory failure when relapses occur, …

… hypersensitivity pneumonitis) [… corticosteroids to be helpful in this situation. In the present
study, amongst the pool of patients prescribed oral corticosteroids for post-COVID / long-COVID …

… In our study, corticosteroids and oxygen therapy were widely employed and provided relief
to the patients, but ultimately, the initiation of alternative anticancer therapies was delayed …

… However, pathology reports from COVID-19 infected lungs also … We hypothesised that in
early COVID-19 pneumonitis, hypoxaemia … Post-study, 14 patients received corticosteroids (…

… Systematic inflammatory mitigation with dexamethasone has been reported to lower the
28-day mortality in patients hospitalized with COVID-19 receiving invasive mechanical …

… pandemic, reflected in a limited number of patients treated with CPAP and also very few
receiving remdesivir (7.0%) or dexamethasone (5.5%), which might alter the outcome on short …

… of pneumonitis that initiates the cascade of acute respiratory distress syndrome (ARDS) of
COVID-19 … Evaluation of COVID-19 Therapy trial, 6 mg per day of dexamethasone for up to 10 …

… The current therapeutic approach to hospitalised patients affected by COVID-19 pneumonitis
includes antivirals (mainly remdesivir), oxygen therapy, proning and corticosteroids, but, …